PharmTech Drug Digest 11.20
News|Articles|November 5, 2014

FDA Specifies DUNS for Drug Facility Registration

FDA releases guidance specifying its preferred unique facility identifier system.

FDA Specifies DUNS for Drug Facility Registration

FDA has released guidance specifying the unique facility identifier (UFI) system for the registration of domestic and foreign drug establishments.  The guidance addresses sections 701 and 702 of the Food and Drug Administration Safety and Innovation Act (FDASIA) that direct FDA to specify the UFI system for registration of domestic and foreign drug establishments.

In the document, FDA states that it is specifying the Data Universal Numbering System (DUNS) number, assigned and managed by Dun and Bradstreet, which FDA has been using since the implementation of electronic drug registration and listing. The DUNS number is available free of charge to all drug establishments, and further information is available on FDA’s website.

Source: FDA


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.